PHARMADANICA A/S: Financial statements 2025
CVR: 19056007
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -339,647 compared with DKK -15,052 the year before. Equity in the 2025 report amounted to DKK 16,646,353. The solvency ratio was 91.6%.
- Profit/Loss
- DKK -339,647
- Equity
- DKK 16,646,353
- Total Assets
- DKK 18,171,936
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -340K | 16.6M | - |
| 2024 | - | - | -15K | 17.5M | - |
| 2023 | - | - | -1.1M | 17.5M | - |
| 2022 | - | - | 476K | 18.6M | - |
| 2021 | - | - | -792K | 18.1M | - |
Official annual report
How creditworthy is PHARMADANICA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout PHARMADANICA A/S
PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.